Literature DB >> 28641553

Capillaroscopy in Routine Diagnostics: Potentials and Limitations.

Francesca Ingegnoli1, Vanessa Smith2, Alberto Sulli3, Maurizio Cutolo3.   

Abstract

BACKGROUND: Nailfold capillaroscopy is a safe and useful investigational tool that allows an early detection and a qualitative description of the microvascular abnormalities in patients with Raynaud's phenomenon secondary to scleroderma-spectrum disorders. Nowadays, the role of capillaroscopy in the diagnosis of systemic sclerosis is well known. Capillaroscopy has been included in the new 2013 classification criteria for systemic sclerosis and is considered a key investigation in the very early phases of the disease.
CONCLUSION: Because of its potential value in monitoring disease progression and treatment response, nailfold capillaroscopy may also have a role in the management of overt systemic sclerosis.
RESULTS: Its application in scleroderma-spectrum disorders in which a microvascular component is suspected may also provide new insights into their pathophysiology. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Nailfold capillaroscopy; Raynaud's phenomenon; autoantibodies; biomarkers; classification criteria; connective tissue diseases; differential diagnosis; imaging; microcirculation; systemic sclerosis; systemic sclerosis.

Mesh:

Year:  2018        PMID: 28641553     DOI: 10.2174/1573397113666170615084229

Source DB:  PubMed          Journal:  Curr Rheumatol Rev        ISSN: 1573-3971


  2 in total

Review 1.  Advances in nailfold capillaroscopic analysis in systemic sclerosis.

Authors:  Barbara Ruaro; Alberto Sulli; Vanessa Smith; Carmen Pizzorni; Sabrina Paolino; Elisa Alessandri; Amelia Chiara Trombetta; Maurizio Cutolo
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09

2.  Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis.

Authors:  Saeedeh Shenavandeh; Farideh Rashidi
Journal:  Reumatologia       Date:  2022-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.